Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " July 10, 2013":" August 09, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" July 10, 2013":" August 09, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (32 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Terminated Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People
Condition: HIV Positive
Intervention:
2 Active, not recruiting Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa
Condition: HIV Infection
Interventions: Drug: monoPI - boosted lopinavir or boosted darunavir;   Drug: bi therapy - (boosted lopinavir or boosted darunavir) + lamivudine
3 Withdrawn Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications
Condition: HIV Infections
Interventions: Biological: GEO-D03 DNA Vaccine;   Biological: MVA/HIV62B Vaccine;   Biological: Placebo for DNA GEO-D03;   Biological: Placebo for MVA/HIV62B Vaccine
4 Completed Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
Condition: HIV-positive
Intervention: Behavioral: SMS reminders
5 Completed An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection
Condition: HIV Infections
Intervention:
6 Unknown  Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire
Condition: HIV Infection
Intervention:
7 Active, not recruiting Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: EVG;   Drug: Background regimen
8 Recruiting Maternal HIV: Trial to Assist Disclosure to Children
Condition: HIV
Intervention: Behavioral: TRACK Intervention
9 Completed X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study
Condition: Hiv Infection
Intervention: Biological: A peripheral blood sample
10 Completed Juvenile Detention to Community Life
Conditions: Substance Use;   Delinquency;   Risk for HIV Infection
Interventions: Behavioral: Multidimensional Family Therapy Cross-Systems;   Behavioral: Enhanced Services as Usual
11 Active, not recruiting Link4Health: A Combination Strategy for Linkage and Retention, Swaziland
Condition: HIV (Human Immunodeficiency Virus)
Interventions: Procedure: POC (point-of-care) CD4+ (cluster of differentiation 4) Count;   Procedure: Accelerated ART (antiretroviral therapy) Initiation;   Behavioral: Basic Care and Prevention Package;   Behavioral: Cellular Appointment Reminders and Follow-Up;   Other: Financial Incentive
12 Recruiting Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Conditions: HIV Infection;   Osteopenia
Interventions: Drug: raltegravir and atazanavir and ritonavir;   Drug: tenofovir/emtricitabine and atazanavir and ritonavir
13 Enrolling by invitation Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men —Test, Link and Care (TLC)
Condition: HIV/AIDS
Intervention: Behavioral: Enhancing HIV testing
14 Completed Mfangano Island Healthy Networks Impact Study
Condition: HIV
Intervention: Behavioral: Mfangano Health Net Microclinic Program
15 Completed Male Engagement in PMTCT Services
Condition: HIV
Interventions: Other: clinic based intervention;   Other: clinic and community based intervention
16 Active, not recruiting Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care
Condition: HIV
Interventions: Other: Same-Day HIV testing and ART initiation;   Other: Standard ART Initiation;   Other: Sub-Study: Same-Day ART, CD4 Count >500;   Other: Sub-Study: Standard Pre-ART Care, CD4 Count >500
17 Completed Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses
Condition: HIV
Interventions: Biological: DNA;   Biological: MVA-C;   Biological: CN54rgp140;   Biological: GLA-AF
18 Recruiting A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)
Condition: HIV
Intervention:
19 Recruiting Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada® for PrEP: A Case Control Study
Condition: HIV
Intervention:
20 Completed Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
Condition: HIV/AIDS
Interventions: Behavioral: Focus On Youth;   Behavioral: Health Education Control Condition

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.